tively seem to comprise the Silicon Valley innovator ethos; most are relevant to healthcare and biopharma, and I agree with all his assertions except one.(Hoffman, for those tuning in late, is a Silicon Valley superstar: he was a major part of PayPal, a co-founder of LinkedIn, and currently a partner at Greylock.)Theme 1: Breakout success requires risk.